Therapeutic Approach

Archive: September, 2015

Ritter Pharmaceuticals to Present at the 3rd Microbiome R&D Business Collaboration Forum

LOS ANGELES (September 8, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (Ritter), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that the Company’s Chief Executive Officer, Michael Step, will participate in the 3rd Microbiome R&D Business Collaboration Forum to be held September 10-11, 2015 […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD